JPWO2021044436A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021044436A5
JPWO2021044436A5 JP2022514468A JP2022514468A JPWO2021044436A5 JP WO2021044436 A5 JPWO2021044436 A5 JP WO2021044436A5 JP 2022514468 A JP2022514468 A JP 2022514468A JP 2022514468 A JP2022514468 A JP 2022514468A JP WO2021044436 A5 JPWO2021044436 A5 JP WO2021044436A5
Authority
JP
Japan
Prior art keywords
antigen
carrier protein
sugar
protein conjugate
salmonella enterica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022514468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546763A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2020/050763 external-priority patent/WO2021044436A2/fr
Publication of JP2022546763A publication Critical patent/JP2022546763A/ja
Publication of JPWO2021044436A5 publication Critical patent/JPWO2021044436A5/ja
Pending legal-status Critical Current

Links

JP2022514468A 2019-09-03 2020-09-02 腸疾患に対する免疫原性組成物およびその調製のための方法 Pending JP2022546763A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201921035435 2019-09-03
IN201921035435 2019-09-03
PCT/IN2020/050763 WO2021044436A2 (fr) 2019-09-03 2020-09-02 Compositions immunogènes contre des maladies entériques et leurs procédés de préparation

Publications (2)

Publication Number Publication Date
JP2022546763A JP2022546763A (ja) 2022-11-08
JPWO2021044436A5 true JPWO2021044436A5 (fr) 2023-08-01

Family

ID=72659843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022514468A Pending JP2022546763A (ja) 2019-09-03 2020-09-02 腸疾患に対する免疫原性組成物およびその調製のための方法

Country Status (20)

Country Link
US (1) US20230149524A1 (fr)
EP (2) EP4249061A3 (fr)
JP (1) JP2022546763A (fr)
KR (1) KR20220087437A (fr)
CN (1) CN114728053A (fr)
AR (1) AR119884A1 (fr)
AU (1) AU2020343943A1 (fr)
BR (1) BR112022003892A2 (fr)
CA (1) CA3149972A1 (fr)
CO (1) CO2022003789A2 (fr)
CR (1) CR20220132A (fr)
EC (1) ECSP22031077A (fr)
GB (1) GB2603362A (fr)
IL (1) IL291006A (fr)
JO (1) JOP20200214A1 (fr)
MA (1) MA56283A1 (fr)
MX (1) MX2022002693A (fr)
PE (1) PE20221442A1 (fr)
WO (1) WO2021044436A2 (fr)
ZA (1) ZA202203368B (fr)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
AU1420897A (en) * 1996-12-18 1998-07-15 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Conjugate vaccine for (salmonella paratyphi) a
AU771330B2 (en) 1998-08-19 2004-03-18 Baxter Healthcare Sa Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
EP1896062B1 (fr) 2005-06-27 2010-03-31 GlaxoSmithKline Biologicals S.A. Composition immunogène
TW201516149A (zh) 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
GB0700135D0 (en) * 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Vaccine
FR2938265B1 (fr) 2008-11-12 2011-07-15 Univ Claude Bernard Lyon Procede pour le pilotage d'un traitement de depolymerisation par ultrasons d'un biopolymere hydrosoluble
BR122022002084B1 (pt) * 2009-12-17 2022-08-16 Fina Biosolutions, Llc Processo de conjugação de carboidratos na preparação de vacinas conjugadas e suas respectivas vacinas
US9011871B2 (en) * 2011-11-07 2015-04-21 University Of Maryland, Baltimore Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease
US9283270B2 (en) * 2012-01-20 2016-03-15 Serum Institute Of India Ltd. Method for stabilization of biological molecules
SI2809349T1 (sl) 2012-01-30 2019-03-29 Serum Institute Of India Private Limited Imunogeni sestavek
CN102935226B (zh) * 2012-11-16 2014-01-22 罗益(无锡)生物制药有限公司 伤寒甲型副伤寒结合疫苗及其制备方法
KR102447303B1 (ko) * 2013-08-24 2022-09-23 브하라트 바이오테크 인터내셔날 리미티드 박테리아성 백신 및 그의 제조방법
EA039487B1 (ru) * 2015-07-04 2022-02-01 Бхарат Байотек Интернэшнл Лимитед Комбинированные полисахаридные вакцинные композиции и способ получения бактериальных капсульных полисахаридов
CA3032901A1 (fr) 2016-08-26 2018-03-01 Serum Institute Of India Private Limited Composition vaccinale multivalente
EP3619241A1 (fr) * 2017-05-05 2020-03-11 Serum Institute Of India Private Limited Procédé d'élimination d'impuretés de préparations à base de polysaccharide capsulaire bactérien
EP3655024A1 (fr) 2017-07-18 2020-05-27 Serum Institute of India Private Limited Composition immunogène à stabilité améliorée, immunogénicité améliorée et moindre réactogénicité, et procédé de préparation de cette dernière
JOP20190242A1 (ar) 2018-10-12 2020-04-12 Serum Institute Of India Pvt Ltd تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها

Similar Documents

Publication Publication Date Title
DK2815762T3 (en) Process for Conjugation of Bacterial Polysaccharides to Carrier Proteins
JP7275277B2 (ja) ストレプトコッカス・ニューモニエ多糖-タンパク質コンジュゲートを含む組成物およびその使用方法
EP2683408B1 (fr) Procédé de conjugaison d'un antigène bactérien à une protéine porteuse
JPWO2021044436A5 (fr)
GB2603362A (en) Immunogenic compositions against enteric diseases and methods for its preparation thereof
US12016914B2 (en) Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
OA20613A (en) Immunogenic compositions against enteric diseases and methods for its preparation thereof.
AU2012101554B4 (en) Conjugation process of bacterial polysaccharides to carrier proteins